d by the Board on October 4, 2013. 5. Nimbus Bridge Financing Next, Ms. Tran and Mr. Griner updated the Board on the bridge financing obtained by Nimbus Discovery, LLC ("Nimbus") in mid-January 2014. Ms. Tran informed the Board that (i) the bridge investors' equity would sit on top of Nimbus' existing investor

ort and collaborations The Principals invested --$30.0M to date. Other investors included D.E. Shaw and related entities and Rich Fricsner Nimbus Nimbus Discovery uses computational technology to develop medicines against hard-to-drug targets. Nimbus Discovery harnesses cutting-edge computational technologies